Diffuse Bio, a leading provider of AI and experimental platforms for designing and screening protein therapeutics, today announced significant enhancements to DiffuseSandbox, its self-serve protein ...

By adding AI-enabled RNA design and active learning, Eclipsebio extends its sequencing-based analytics platform into a fully ...

Eclipsebio has acquired Terrain Bio, a techbio company specializing in AI/ML RNA design and manufacturing analytics.

Dash Bio, the bioanalysis CRO redefining speed in drug development, announced it has moved into a new 24,000 square foot ...

The American Federation for Aging Research (AFAR) is pleased to announce the release of silverlinings.bio , an interactive report and ...

This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilitiesThe ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing ...

Cabaletta Bio (CABA) advances engineered cell therapies for autoimmune disease; insider buying boosts confidence. Click here ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

The vaginal microbiota is shaped by bacterial access to specific nutritional resources, influencing health outcomes. This study uses a resource-based model supported by clinical data to identify key ...